FindTrial
Sign In

For patients undergoing surgeries of arm and shoulder we will use regional anesthesia using ultrasound and study the effect of two local anesthestic agents (bupivacaine and ropivacaine) along with magnesium sulphate.

Effect of magnesium sulphate as an adjunct to bupivacaine and ropivacaine for ultrasound guided interscalene brachial plexus block.

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/01/006499
Enrollment
60
Registered
2016-01-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA class I-II. Undergoing surgeries of shoulder and arm.

Interventions

Intervention1: GROUP B: 20 mL of 0.5% Bupivacaine + 150 mg MgSO4 (3 mL of 50:1 solution)for brachial plexus block using interscalene approach and ultrasound guidance for peroperative anesthesia and po

Sponsors

Department of Anesthesia
Lead Sponsor
Dr Versha Verma
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: ASA class I-II. Undergoing surgeries of shoulder and arm.

Exclusion criteria

Exclusion criteria: Patients refusal for block. Severe pulmonary disease or contralateral phrenic nerve palsy. History of cardiac , renal or hepatic disease , CNS disorders, neuropathy. Chronic treatment with calcium channel blockers. Patients having bleeding disorders. Hypersensitivity to local anaesthetics. Local infection at the site where needle for block is to be inserted. Forearm and hand surgery. Allergic to study drugs. Patients in whom the block effect will be partial and will require supplementary anesthesia.

Design outcomes

Primary

MeasureTime frame
Onset of sensory block. Onset of motor block. Duration of sensory block. Duration of motor block. Duration of analgesia.Timepoint: Within first 24 hrs of surgery—

Secondary

MeasureTime frame
Total analgesics requirement. Complications and side effects if any. Timepoint: Within first 24 hrs of surgery—

Countries

India

Contacts

Public ContactDr Anshit

DRPGMC Kangra at Tanda

versha2u@yahoo.co.in9418152286

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026